twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2018
vol. 120
 
Share:
Share:
abstract:
Review paper

The position of biologic therapies in the treatment of non-infectious uveitis. Part II

Maja Waszczyk-Łączak
,
Jacek P. Szaflik

Online publish date: 2018/10/25
View full text Get citation
 
PlumX metrics:
Non-infectious uveitis is a heterogeneous group of diseases, which share a common denominator, that is, the inflammation within the structure of the eye. The goal of treatment in non-infectious uveitis is to inhibit the abnormal immune response. Glucocorticoids are still the basic therapy followed by immunosuppressants should there be no response to the first line treatment. Systemic biologic agents are another alternative. Biological therapy involves the administration of substances intended to bind to the specific molecules which trigger the inflammatory response. Biologic agents are defined as bioengineered receptor complexes, antibodies, Fab fragments, and agents such as interferons that affect the expression of pro-and anti-inflammatory components of the immune system. In the article, the drugs, which inhibit interleukin-6, interleukin-1, interleukin-2 as well as anti-CD20 immunoglobulins and interferons will be discussed.
keywords:

interleukins, biological therapy, non-infectious uveitis, anti-CD20 antibody, interferons

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.